Physician profile
Morris Baumgarten
NPI 1477571834
$1,664.18
in general payments reported to CMS, 2019-2025
12 companies · $772 in 2025
The $772 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $17.97 · 2021: $189 · 2022: $76.77 · 2023: $120 · 2024: $322 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,213.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $531.92 | 2025 | Mako |
| Zimmer Biomet Holdings, INC. | $409.14 | 2019-2025 | Samples Biologics, Gel-One Cross-Linked Hyaluronate, Avenir |
| Smith+Nephew, INC. | $269.16 | 2024-2025 | Legion, Real Intelligence |
| Next Science LLC | $156.03 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $73.60 | 2025 | |
| Globus Medical, INC. | $63.44 | 2022 | |
| Ethicon US, LLC | $46.94 | 2019-2024 | Echelon Flex |
| Kowa Pharmaceuticals America, INC. | $44.73 | 2023 | Seglentis |
| Saxum Surgical, INC. | $20.18 | 2023 | |
| Terumo Bct, INC. | $19.67 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.04 | 2019 | |
| Paragon 28, INC. | $13.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morris Baumgarten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.